CLNN Similar Chart Price Prediction
The price of CLNN is predicted to go up 7.38%, based on the high correlation periods with SHCO. The similarity of these two price pattern on the periods is 92.49%.
CLNN
SHCO
Up: 7.38%Similarity: 92.49%
CLNN Revenue Forecast
CLNN EPS Forecast
CLNN FAQs
What is bull’s view on CLNN?
What is bear's view on CLNN?
What is CLNN revenue forecast for next quarter？
CLNN Analyst's Forecast
Bruce Jackson
Benchmark
Strong Buy
2024-11-22
Price Target
$90 → $84
Downside
0%
Benchmark lowered the firm's price target on Clene to $84 from $90 and keeps a Buy rating on the shares, noting that management and a group of key opinion leaders met in-person with the FDA on November 1 in a Type C meeting to discuss the potential for an accelerated approval pathway for CNM-Au8 in the treatment of ALS. If the FDA is amenable to the use of biomarker data and survival endpoints, the firm believes it could favorably impact the trial design and shorten the time to market, notes the analyst, who cites updating the model for the 10-Q with new share count assumptions for the firm's lower price target.
Sumant Kulkarni
Canaccord Genuity
Strong Buy
2024-11-14
Price Target
$86 → $83
Downside
0%
Sumant Kulkarni
Canaccord Genuity
Strong Buy
2024-10-04
Price Target
$94 → $86
Downside
0%
